Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.4.6 (
urease
)
7,490
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The formation of some urinary tract stones (struvite stones) is known to be related to infection by
urease
-possessing microorganisms, such as Proteus sp. and some other bacteria. Ureaplasma urealyticum, a genital mycoplasma, contains also
urease
and is predominantly located in the urogenital tract. Its significance in the production of human urinary stones has not yet been elucidated. In this study, 135 human calculi obtained by surgery were analysed chemically and were cultured for the presence of conventional bacteria and U. urealyticum, 51 were ammonium magnesium
phosphate
stones and contained Proteus (27), E. coli (4), Staphylococcus epidermidis (3), Streptococcus D (2), Pseudomonas aeruginosa (1), Staphylococcus aureus (1), Corynebacterium (1), Candida albicans (1). U. urealyticum was isolated in one patient, from two different calculi (left and right) taken after an interval of fifteen days. Different bacteria were isolated from other calculi (oxalate, uric acid). This findings suggest that Ureaplasma urealyticum should be looked for in struvite calculi.
...
PMID:[Comparative bacteriological and chemical analysis of kidney calculi. Apropos of 135 cases]. 653 Oct 61
Phosphate
stones are divided in two groups: I. Infection stones = triple
phosphate
stones (struvite and carbonate apatite). II. Calcium
phosphate
stones = Hydroxy apatite. Ad I. For the formation of this stone, infection with
urease
-producing bacteria is essential. It is important to look for factors that cause infection and for metabolic abnormalities. Three possibilities for treatment are discussed: Acidifying the urine: orally with NH4NO3 or NH4Cl; dosage is possible up to 12 g a day (metabolic acidosis!). Irrigation for instance with Renacidin ; when using a nephrostomy-tube, one can start 5 days after the operation. It is important to look for fever and flank pain. Especially useful in cases with small residual stones. Reduction of
phosphate
excretion in urine ( Shorr -regimen). Some aluminium combinations reduce the intestinal
phosphate
absorption as a result of the formation of a nonabsorbable aluminium-
phosphate
combination. This can be combined with a low calcium- and
phosphate
diet. In several publications good results are shown. Also when using a less rigid regimen, satisfactory results are seen: decrease of the
phosphate
excretion from 30 to 17 mmol/24 h (own investigation). Urease-inhibitors result in a lower urine-pH and a decrease of the ammonium-concentration. there are only a few publications with results, but AHA seems able to reduce the stone size in 24% of the patients. Ad II. This stone is concerning formation and treatment much like the calcium oxalate stone. In case of an alkaline urine one must look for primary hyperparathyroidism and renal tubular acidosis.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:[Conservative therapy of phosphate calculi]. 653 26
Hydroxamic acid, a potent
urease
inhibitor, having a high urinary excretion rate is expected to be a therapeutic agent for urolithiasis caused by urea-splitting bacterial infection of the urinary tract. Twenty-one new derivatives of N-aliphatic-acylglycinohydroxamic acids (GHAs) were synthesized, and their inhibitory potencies against the
urease
activity of sword bean in a
phosphate
buffer and against the ureolytic activity of Proteus mirabilis in human urine, and their urinary excretion rates in rats were also measured for this purpose I50 values of most of GHAs against the
urease
activity of sword bean were about 1 to 10 microM and 2-ethyl-n-butyroyl GHA was the most potent inhibitor with the value of 0.79 microM. I50 values of most of the GHAs against the ureolytic activity of Proteus mirabilis were about 5 to 50 microM and n-nonaroyl GHA was the most potent inhibitor with the value of 3.6 microM. 2,2-Dimethylpropionyl GHA had the highest urinary excretion rate with the recovery of 11%. Routes of administration of 2,2-dimethylpropionyl GHA and sex of rats used did not affect the amount of urinary excretion at all. The results in this report suggest that DL 2-methyl-n-butyroyl, 2-ethyl-n-butyroyl and 2,2-dimethylpropionyl GHA are the most hopeful therapeutic agents for urolithiasis among them.
...
PMID:Therapy for urolithiasis by hydroxamic acids. III. Urease inhibitory potency and urinary excretion rate of N-acylglycinohydroxamic acids. 700 14
The factors of infective calculus formation and the conditions favoring their prevention were studied by examining in vitro the role of the most common representative of
urease
-producing bacteria, Proteus mirabilis. The stream of Proteus-containing urine was found to form deposits of magnesium ammonium
phosphate
, carbonate apatite and ammonium-urate on the glass surfaces. Application either of mandelic acid or of Gentamycin was found to reduce the production of these deposits, and their joint application proved fully preventive to their formation. Gentamycin applied in saline acidified with mandelic acid was capable of dissolving previously formed crystals. A medication of this composition is advocated for preventive use after surgery for staghorn calculi. The necessity for continuing peroral medication and specific antibacterial therapy for months is emphasized.
...
PMID:Study of infective (secondary) renal calculus formation in vitro. 702 70
A membrane filter procedure was developed for the isolation of Yersinia enterocolitica from aquatic environments. Primary differentiation was based on the fermentation of sorbitol, the absence of lysine decarboxylase and arginine decarboxylase-dihydrolase activities, and the production of
urease
. Sodium deoxycholate was incorporated as an inhibitor of background organisms. The presumptive identification of Y. enterocolitica was accomplished in 50 h, and the rate of identity confirmation of typical colonies was 88%. The mean recovery rate of 15 strains from
phosphate
buffer suspensions was 91%, and quantitative recovery was demonstrated for low populations of the organism in both laboratory-prepared and naturally occurring mixed cultures. The technique was used to isolate 33 strains of Y. enterocolitica from 15 of 27 river water samples and from prechlorinated sewage effluent. Nine (27%) of the isolates were rhamnose positive, and only five (15%) were serotypable. Two isolates were identified as serotype O:4 (or O:4,32), two were O:17, and the fifth was O:40.
...
PMID:Membrane filter technique for the isolation of Yersinia enterocolitica. 708 85
Struvite (magnesium ammonium
phosphate
) uroliths are found more frequently in the urinary tracts, of dogs than are other types of uroliths. Infection of the urinary tract with
urease
-producing bacteria, especially staphylococci, plays an important role in urolith formation. An inherited predisposition to urinary tract infection may be associated with the high rat of occurrence of struvite uroliths in some dogs. Diagnosis of struvite urolithiasis should encompass analysis of the mineral composition of calculi and identification of concomitant urinary tract infection. Since urinary tract infections occur as sequelae to abnormalities in local or systemic host-defense mechanisms, appropriate effort should be directed toward detection of these abnormalities. Therapy of struvite urolithiasis should encompass relief of obstruction to outflow when necessary, elimination of existing calculi, eradication or control of urinary tract infection, and prevention of recurrence. Although surgical removal remains as the preferred method to eliminate struvite uroliths from dogs, nonsurgical methods of urolith dissolution should be considered. Recurrence of struvite uroliths may be prevented by various combinations of antimicrobial therapy, administration of
urease
inhibitors, acidification of urine, and induction of diuresis.
...
PMID:Canine struvite urolithiasis: problems and their dissolution. 728 47
Magnesium ammonium
phosphate
calculi developed in the urinary bladders and urethras of four of five offspring of Miniature Schnauzer parents with recurrent struvite urolithiasis. Calculi were detected by radiograhy when the dogs were 12 to 15 months old. Males and females were affected. A significant number of
urease
-producing staphylococci were identified in the urine of three of four dogs before urolith formation, and in one dog after urolith formation. The dogs were evaluated until they were 26 months old. Serum concentrations of calcium, phosphorus, and magnesium were inside usual limits throughout the study. Abnormalities that might predispose to urinary tract infection were not identified by radiography or necropsy studies. In one dog, bladder calculi recurred after surgical removal of multiple cystoliths. In another, urethral obstruction and acute generalized pyelonephritis induced a lethal uremic crisis. Gross and microscopic lesions, detected after necropsy of all dogs with uroliths, were typical of bacterial infection.
...
PMID:Struvite urolithiasis in a litter of miniature Schnauzer dogs. 740 90
Escherichia coli (E. coli) is usually not a
urease
producer. It is, however, often cultured in urinary
phosphate
containing calculi including ammonium magnesium
phosphate
stones. This suggests the possibility that E. coli might be involved in stone forming process. The effect of E. coli on urine citrate and
urease
-induced crystallization in human urine has been studied in vitro. E. coli was found to strongly reduce urine citrate (after 48 hours). In the E. coli inoculated samples, the
urease
-induced crystallization was increased. There was a strong correlation, r = 0.8, between the citrate decrease and the increase in calcium precipitation. The results indicate that E. coli and the reduced urine citrate influences
urease
-induced crystallization in vitro.
...
PMID:Impact of Escherichia coli on urine citrate and urease-induced crystallization. 750 98
Helicobacter pylori is a bacterial pathogen of humans that infects the gastric mucosa. This infection has been associated with gastritis, peptic ulcers, and gastric carcinomas. Diverse in vitro studies have described efficient adherence of H. pylori to different types of epithelial cells. Because of its varied effects on host cells, we have analysed signal transduction events in H. pylori-infected epithelial cells. Our results show that H. pylori induces an increase in inositol phosphates in all cultured epithelial cells used, including HeLa, Henle 407, Hep-2, and the human gastric adenocarcinoma cell line AGS. Bacterial growth medium supernatants induce a similar response in the host cell. The increase in inositol phosphates is not related to redistribution of cytoskeletal proteins such as actin or alpha-actinin nor tyrosine-phosphorylation of host cell proteins. The inositol
phosphate
increase is also observed in cells infected with low or non-adherent H. pylori mutants or mutants defective in the vacuolating toxin or
urease
holoenzyme. These results indicate that inositol
phosphate
release in H. pylori-infected cells is not dependent on bacterial adherence, and that a soluble bacterial factor, but not the vacuolating toxin or
urease
holoenzyme, mediates such an effect.
...
PMID:Helicobacter pylori induces an increase in inositol phosphates in cultured epithelial cells. 760 12
The influence of four inhibitors: boric acid, thioglycolic acid, sodium fluoride and acetohydroxamic acid on the activity of
urease
, both in the native form and immobilized covalently on glutaraldehyde-pretreated chitosan membrane, was studied. Urea hydrolysis was carried out in
phosphate
buffer, pH 7, at 25 degrees C at urea concentration of 50 mM. The immobilized
urease
was more resistant than the native one to the action of all the investigated inhibitors, except boric acid. This property of the enzyme offers a possibility of its practical application.
...
PMID:Competitive inhibitors of free and chitosan-immobilized urease. 765 53
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>